ANTWAN LACY: Open Payments
NPI 1477059376 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,822 in 87 payments from 9 companies in 2025. Trend: 2023 $1,840 · 2024 $1,801 · 2025 $12,822
Speaker / faculty: $6,110Consulting: $3,000Food & beverage: $2,078Travel & lodging: $1,634
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 49 | $12,077 |
| ViiV Healthcare Company | 13 | $278 |
| ABBVIE INC. | 6 | $121 |
| Novo Nordisk Inc | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Amgen Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
Products named: Biktarvy, Yeztugo, QULIPTA, CABENUVA, APRETUDE, AIRSUPRA, XIFAXAN, DOVATO.
Industry payments across FL — which companies pay providers there.
